The journey from scattered notes on a cocktail napkin to a licensed medical technology can be daunting—a quest packed with high attrition rates and the risks that come from the dynamic nature of science and the marketplace.
Discover some of the latest licensing deals executed by Wake Forest Innovations. In this report, learn about the licensing of novel technologies: a cancer therapeutic, a graft for heart valve replacement and a delivery method for oral medications.
Pappas Capital and Wake Forest Innovations today announced the first technologies to receive initial investment from the Catalyst Fund, the $15 million technology development program established by Wake Forest Baptist Medical Center in October 2015.
Local and national critical care experts will gather at the Bowman Gray Center for Medical Education on January 9 for the Sepsis Summit, presented by the Critical Illness, Injury and Recovery Research Center (CIIRRC) of the Wake Forest School of Medicine.
Wake Forest Innovations would like to introduce the two newest members of the Center for Industry Research Collaboration.
Early-stage research successes are like good love stories. Both require a serendipitous connection and a happy ending. For faculty researchers, those happy endings often involve grant funds, and this year two researchers at Wake Forest Baptist Medical Center received a BIG grant.
Two new health IT technologies developed by Wake Forest Baptist Medical Center researchers and undergoing technology development through Wake Forest Innovations are vying for top honors at upcoming events that will award funding dollars.
Wake Forest University was named in the Top 100 Worldwide Universities Granted U.S. Utility Patents for 2015. The list recognizes both the importance of patents in academic innovation and the work that universities like Wake Forest do in producing new technologies that improve the human condition.
Mitochondria power cellular function, but they energize the research of Anthony Molina, PhD, assistant professor of gerontology and geriatric medicine at Wake Forest Baptist Medical Center, in a different sort of way.
Art Pappas, life science investor and managing partner of Pappas Ventures, delivered the keynote address at the 2016 Open Thinking Innovation Showcase, an event held by Wake Forest Innovations to show off new and upcoming inventions from researchers at Wake Forest School of Medicine and Wake Forest University.